Choreo LLC’s BioNTech BNTX Stock Holding History

Choreo LLC’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,755	Closed	-$690K	–	1635
2024 Q2	$690K	Buy	+8,755	New	+$800K	0.01%	671

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Choreo LLC's BNTX Position: Q3 2024 in Review

Choreo LLC sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 8,755 shares — an estimated $690K sold.

Choreo LLC first reported a position in BNTX in Q2 2024 and held it in 1 quarter. The position peaked at $690K in Q2 2024. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

Choreo LLC reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
Choreo LLC sold 8,755 BioNTech shares in Q3 2024, an estimated $690K.
Choreo LLC first reported a position in BioNTech in Q2 2024 and held it in 1 quarter.
Choreo LLC's BioNTech position peaked at $690K in Q2 2024.
296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Choreo LLC's 13F filing for Q3 2024, filed 7 Nov 2024.